The mammalian target of rapamycin (mTOR) is a protein kinase that controls cellular
metabolism, catabolism, immune responses, autophagy, survival, proliferation, and …

Simple Summary In recent years, several therapeutic advances have been made in clear
cell renal cell carcinoma (ccRCC) resulting in novel treatment regimens of increased …

Background Preclinical models suggest synergy between anti-angiogenesis therapy,
mammalian target of rapamycin (mTOR), and histone deacetylase inhibitors to promote …

Introduction Mammalian target of rapamycin (mTOR) inhibitors-associated pneumonitis
(mTOR-IP) has long been described in solid organ recipients (T) patients but more recently …